Used in research for the treatment of prostate cancer, particularly in cases of castration-resistant prostate cancer. It functions as an inhibitor of androgen biosynthesis, targeting key enzymes such as CYP17A1 involved in the production of androgens that fuel tumor growth. This compound is of interest in oncology for its potential to reduce the levels of active androgens within tumor tissues, thereby helping to slow disease progression. It may be used in research and development of therapies aimed at overcoming resistance to standard hormonal treatments.